#Semaglutide

[ follow ]
#ozempic #weight-loss #tirzepatide #obesity #type-2-diabetes #glp-1-agonists #obesity-treatment
fromPsychology Today
5 days ago

Body Image in the Ozempic Era

Before I explain, I want to clarify that I firmly believe in body autonomy. If someone chooses to take a weight loss medication, they should be able to do so without judgment. I hope all potential users are fully informed about the risks and benefits of these medications and are followed responsibly by medical providers. Ideally, they would also be screened for a current or past eating disorder or any other condition that might contraindicate the use of GLP-1s and GIPs.
Medicine
Medicine
fromHarvard Gazette
1 week ago

Weight-loss drugs reduce risk of heart failure by 40% - Harvard Gazette

Semaglutide or tirzepatide initiation is associated with over 40% lower risk of hospitalization or death in high-risk HFpEF patients with obesity and Type 2 diabetes.
Medicine
fromwww.theguardian.com
2 weeks ago

Weight loss drugs can halve heart patients' risk of early death, study finds

GLP-1 agonist weight-loss drugs substantially reduce hospitalization and premature death risk in obese heart failure patients with type 2 diabetes, up to 58%.
#ozempic
Alternative medicine
fromenglish.elpais.com
4 months ago

The Ozempic universe expands: These drugs also treat fatty liver disease

Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.
more#ozempic
fromwww.bbc.com
1 month ago

Weight-loss: Are injections the answer to tackling obesity?

Semaglutide mimics a hormone that is released when we eat, tricking the brain into thinking we are full and dialing down appetite.
Health
fromFuturism
1 month ago

The Creator of Ozempic Is in Terrible Trouble

Novo Nordisk, creator of the mega-hit drug Ozempic, has seen a loss of nearly $100 billion in market value due to collapsing sales and missed forecasts.
Healthcare
#semaglutide
Medicine
fromwww.nytimes.com
4 months ago

Wegovy Can Treat a Dangerous Liver Disease, Study Finds

Semaglutide, a weight-loss drug, shows promise in treating metabolic dysfunction-associated steatohepatitis, a severe liver disease affecting millions.
more#semaglutide
Right-wing politics
fromThe American Conservative
2 months ago

The FTC Has the Chance to Rein in Big Pharma

Big Pharma's actions regarding necessary medicines, particularly semaglutide, require careful regulation.
Reliance on two manufacturers for crucial diabetes and obesity drugs poses significant risks to patients.
[ Load more ]